Designation and Principal Amount; Series Treatment Clause Samples

Designation and Principal Amount; Series Treatment. The Issuers hereby establish a series of Securities designated the “5.500% Senior Notes due 2030” for issuance under the Indenture. The Notes may be authenticated and delivered under the Indenture in an unlimited aggregate principal amount. The Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an aggregate principal amount of $500,000,000. The Notes are unsecured and shall rank equally with the Issuers’ other unsecured and unsubordinated indebtedness. The Notes issued on the date hereof will be issued at a price of 99.858% of the aggregate principal amount. (a) The Issuers may, from time to time, without the consent of the Holders of the Notes, issue Additional Notes, so that such Additional Notes and the outstanding Notes of such series shall be consolidated together and form a single series of Securities under the Indenture. Any increase in the aggregate principal amount of any series of Notes shall be evidenced by a written order and an Officer’s Certificate to be delivered to the Trustee, without any further action by the Issuers. (b) Any Additional Notes issued under Section 2.01(a) shall have the same terms in all respects as the Notes herein provided for, except for the issue date, the initial public offering price and, if applicable, the payment of interest accruing prior to the issue date or the first Interest Payment Date of such Additional Notes; provided that, if such Additional Notes are not fungible with the Notes for U.S. Federal income tax purposes, such Additional Notes shall have a separate CUSIP number.